IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—17 September 2013

3:40 AM MDT | September 17, 2013 | Deepti Ramesh

ICIG to acquire peptide APIs firm Peptisyntha from Solvay International Chemical Investors Group (ICIG), a privately owned industrial holding company, says that it has entered into an agreement with Solvay to acquire the latter's subsidiary Peptisyntha (Brussels), a custom manufacturer of peptides for pharmaceutical use. Financial details of the deal have not been disclosed. The transaction is expected to be completed this fall, and Peptisyntha will become a member of ICIG's CordenPharma platform as its third site offering peptides manufacturing. For Solvay, the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa